Pacer Advisors
CRGX

Pacer Advisors’s CARGO Therapeutics CRGX Stock Holding History

Pacer Advisors’s Portfolio CRGX Stock Details CRGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-230
Closed -$3.78K – 2592
2024
Q2 		$3.78K Buy
230
+5
+2% +$95 ﹤0.01% 3657
2024
Q1 		$5.02K Buy
+225
New +$5.35K ﹤0.01% 3594

Other funds holding CRGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Pacer Advisors's CRGX Position: Q3 2024 in Review

Pacer Advisors sold out of CARGO Therapeutics (CRGX) in Q3 2024, closing a stake of 230 shares — an estimated $3.78K sold.

Pacer Advisors first reported a position in CRGX in Q1 2024 and held it in 2 quarters. The position peaked at $5.02K in Q1 2024. 79 funds tracked by Wall St. Rank hold CRGX as of Q3 2024.

  • Pacer Advisors reported no remaining CARGO Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Pacer Advisors sold 230 CARGO Therapeutics shares in Q3 2024, an estimated $3.78K.
  • Pacer Advisors first reported a position in CARGO Therapeutics in Q1 2024 and held it in 2 quarters.
  • Pacer Advisors's CARGO Therapeutics position peaked at $5.02K in Q1 2024.
  • 79 funds tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2024.

Based on Pacer Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.